Using a CRISPR-based biosensor platform, researchers have detected microRNA biomarkers of Alzheimer’s disease, with the opportunity to expand into a multiplexed assay to improve diagnostics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results